MVIS® US Listed Pharmaceutical 25 Index

The MVIS® US Listed Pharmaceutical 25 Index (MVPPH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the pharmaceutical industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from pharmaceutical related products and services, such as research and development, production, or marketing and sales.

Country and Sector Weightings

MVIS Sector Indices are pure-play sector indices. Companies must generate at least 50% of their revenues in the target sector to be eligible for index inclusion. Country and Sector weightings are based on the weightings of all index components in a certain country or sector.

CountryComponentsWeight
Canada1 0.65%
United States13 54.96%
Denmark1 5.29%
France1 4.71%
Ireland2 3.39%
Netherlands1 3.72%
Switzerland1 5.06%
United Kingdom3 14.71%
Israel1 2.91%
Japan1 4.60%
Total25 100.00%
SectorComponentsWeight
Consumer Staples1 5.01%
Health Care24 94.99%
Total25 100.00%

Size Weightings

  • Large-Cap: companies with a market capitalisation above 6,000 mln USD
  • Mid-Cap: companies with a market capitalisation from 1,500 mln to 6,000 mln USD
  • Small-Cap: companies with a market capitalisation from 200 mln to 1,500 mln USD
  • Micro-Cap: companies with a market capitalisation up to 200 mln USD
SizeMarket CapComponentsWeight
Large-Cap2,905,326,870,600 USD21 96.85%
Mid-Cap15,729,369,100 USD4 3.15%
Small-Cap---
Micro-Cap---
Total2,921,056,239,700 USD25 100.00%
Up